$Evaluating the antifracture efficacy of bisphosphonates.$

Evaluating the antifracture efficacy of bisphosphonates.

Oral bisphosphonate dosing schedules have evolved from the original daily regimens to weekly (alendronate and risedronate) and monthly (risedronate and ibandronate) regimens. Intravenous (i.v.) bisphosphonates are administered less frequently-quarterly ibandronate injection and yearly zoledronic aci...

Полное описание

Библиографические подробности
Главные авторы:	Pazianas, M, Epstein, S, Zaidi, M
Формат:	Journal article
Язык:	English
Опубликовано:	2009

Схожие документы

Antifracture agents for prostate cancer patients on androgen deprivation therapy
по: Bhupendra P Singh, и др.
Опубликовано: (2010-01-01)

The sequential antifracturative treatment: a meta-analysis of randomized clinical trials
по: Angelo Fassio, и др.
Опубликовано: (2024-04-01)

Safety of bisphosphonates.
по: Pazianas, M, и др.
Опубликовано: (2011)

Bisphosphonates and bone quality.
по: Pazianas, M, и др.
Опубликовано: (2014)

Atrial fibrillation and bisphosphonate therapy.
по: Pazianas, M, и др.
Опубликовано: (2010)

Potential therapeutic effects of oral bisphosphonates on the intestine.
по: Pazianas, M, и др.
Опубликовано: (2011)

Safety issues with bisphosphonate therapy for osteoporosis.
по: Suresh, E, и др.
Опубликовано: (2014)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
по: Pazianas, M
Опубликовано: (2013)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
по: Alexander J Rodríguez, и др.
Опубликовано: (2022-06-01)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
по: Alexander J Rodríguez, и др.
Опубликовано: (2021-07-01)

Bisphosphonates and colon cancer: reply.
по: Pazianas, M, и др.
Опубликовано: (2013)

Bisphosphonates and colon cancer: Reply
по: Pazianas, M, и др.
Опубликовано: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates.
по: Pazianas, M, и др.
Опубликовано: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates
по: Pazianas M, и др.
Опубликовано: (2013-10-01)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
по: Michael Pazianas
Опубликовано: (2021-08-01)

Atrial fibrillation and the use of oral bisphosphonates.
по: Pazianas, M, и др.
Опубликовано: (2011)

Atrial fibrillation and the use of oral bisphosphonates
по: Michael Pazianas, и др.
Опубликовано: (2011-03-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
по: Pazianas, M, и др.
Опубликовано: (2010)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
по: Abrahamsen, B, и др.
Опубликовано: (2013)

NO ASSOCIATION BETWEEN THE USE OF ORAL BISPHOSPHONATES AND INCIDENCE OF ATRIAL FIBRILLATION
по: Pazianas, M, и др.
Опубликовано: (2010)

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
по: Pazianas, M, и др.
Опубликовано: (2014)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
по: Pazianas, M, и др.
Опубликовано: (2008)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: Reply to Yarom and Elad
по: Pazianas, M, и др.
Опубликовано: (2008)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
по: Pazianas, M, и др.
Опубликовано: (2007)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
по: Garriga, C, и др.
Опубликовано: (2018)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
по: Pazianas, M, и др.
Опубликовано: (2012)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
по: Pazianas, M, и др.
Опубликовано: (2013)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
по: Garriga, C, и др.
Опубликовано: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
по: Garriga, C, и др.
Опубликовано: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
по: Garriga, C, и др.
Опубликовано: (2017)

Bisphosphonates
по: Bishop, N, и др.
Опубликовано: (2013)

Bisphosphonates
по: Fırat Öztürk
Опубликовано: (2009-04-01)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
по: Russell, R, и др.
Опубликовано: (2007)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
по: Russell, R, и др.
Опубликовано: (2007)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
по: Sujata Sharma, и др.
Опубликовано: (2023-04-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
по: İlke Coşkun Benlidayı, и др.
Опубликовано: (2015-08-01)

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
по: Russell, R, и др.
Опубликовано: (2008)

Bisphosphonates: An update
по: Nalliappan Ganapathy, и др.
Опубликовано: (2012-01-01)

Bisphosphonates 2006
по: Russell, R
Опубликовано: (2006)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
по: Pazianas, M, и др.
Опубликовано: (2012)